Literature DB >> 23576221

Partition testing in confirmatory adaptive designs with structured objectives.

Toshifumi Sugitani1, Toshimitsu Hamasaki, Chikuma Hamada.   

Abstract

In this paper, we propose a partition testing for adaptive clinical trials with structured study objectives. The proposed approach is a combination of the graphical approach with partition testing. The proposed approach enables one to handle many types of structured objectives, to tailor a multiple test procedure to given structured objectives, and to draw sensible conclusions in adaptive clinical trials. In addition, the proposed approach reduces to the Bonferroni-based graphical approaches that can allow adaptations such as treatment selection and sample size reassessment during the course of the trial. Some practical aspects of the proposed approach are investigated via a simulation study.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2013        PMID: 23576221     DOI: 10.1002/bimj.201200218

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  4 in total

1.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

2.  Adaptive graph-based multiple testing procedures.

Authors:  Florian Klinglmueller; Martin Posch; Franz Koenig
Journal:  Pharm Stat       Date:  2014-10-16       Impact factor: 1.894

3.  A simple and flexible graphical approach for adaptive group-sequential clinical trials.

Authors:  Toshifumi Sugitani; Frank Bretz; Willi Maurer
Journal:  J Biopharm Stat       Date:  2014-11-05       Impact factor: 1.051

4.  Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.

Authors:  Alexandra C Graf; Peter Bauer; Ekkehard Glimm; Franz Koenig
Journal:  Biom J       Date:  2014-04-22       Impact factor: 2.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.